Proposed LCD DL39314: Off-Label Use of Intravenous Immune Globulin (IVIG) — NGS
Policy LCD-DL39314 · Allergy/Immunology
Impact of off-label IVIG use on Medicare billing.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code D89.89.
Signal breakdown
1 shown · 1 total in platform
Critical
0%
High
100%
Routine
0%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-DL39314 · Allergy/Immunology
Impact of off-label IVIG use on Medicare billing.
Audit documentation
The Tripwire Audit Pack exports 12 months of Allergy/Immunology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.